Logo image of DRW8.DE

DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:DRW8 - DE0005550602 - Common Stock

56.7 EUR
-0.3 (-0.53%)
Last: 12/29/2025, 10:59:49 AM
Fundamental Rating

5

Taking everything into account, DRW8 scores 5 out of 10 in our fundamental rating. DRW8 was compared to 62 industry peers in the Health Care Equipment & Supplies industry. DRW8 has only an average score on both its financial health and profitability. DRW8 is valued quite cheap, while showing a decent growth score. This is a good combination! Finally DRW8 also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year DRW8 was profitable.
DRW8 had a positive operating cash flow in the past year.
Of the past 5 years DRW8 4 years were profitable.
DRW8 had a positive operating cash flow in 4 of the past 5 years.
DRW8.DE Yearly Net Income VS EBIT VS OCF VS FCFDRW8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.99%, DRW8 is in line with its industry, outperforming 59.68% of the companies in the same industry.
With a Return On Equity value of 8.02%, DRW8 perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
DRW8 has a better Return On Invested Capital (7.67%) than 66.13% of its industry peers.
Industry RankSector Rank
ROA 3.99%
ROE 8.02%
ROIC 7.67%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
DRW8.DE Yearly ROA, ROE, ROICDRW8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

DRW8 has a Profit Margin (3.54%) which is in line with its industry peers.
DRW8's Profit Margin has improved in the last couple of years.
DRW8 has a Operating Margin (6.02%) which is comparable to the rest of the industry.
DRW8's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 45.35%, DRW8 is doing worse than 66.13% of the companies in the same industry.
DRW8's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.02%
PM (TTM) 3.54%
GM 45.35%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
DRW8.DE Yearly Profit, Operating, Gross MarginsDRW8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

DRW8 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for DRW8 has been reduced compared to 1 year ago.
DRW8 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DRW8 has been reduced compared to a year ago.
DRW8.DE Yearly Shares OutstandingDRW8.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
DRW8.DE Yearly Total Debt VS Total AssetsDRW8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

DRW8 has an Altman-Z score of 2.64. This is not the best score and indicates that DRW8 is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of DRW8 (2.64) is comparable to the rest of the industry.
The Debt to FCF ratio of DRW8 is 2.16, which is a good value as it means it would take DRW8, 2.16 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.16, DRW8 is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that DRW8 is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, DRW8 is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.16
Altman-Z 2.64
ROIC/WACC1.18
WACC6.49%
DRW8.DE Yearly LT Debt VS Equity VS FCFDRW8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.76 indicates that DRW8 should not have too much problems paying its short term obligations.
DRW8's Current ratio of 1.76 is in line compared to the rest of the industry. DRW8 outperforms 58.06% of its industry peers.
DRW8 has a Quick Ratio of 1.03. This is a normal value and indicates that DRW8 is financially healthy and should not expect problems in meeting its short term obligations.
DRW8's Quick ratio of 1.03 is in line compared to the rest of the industry. DRW8 outperforms 45.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.03
DRW8.DE Yearly Current Assets VS Current LiabilitesDRW8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.68% over the past year.
DRW8 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 36.42% yearly.
Looking at the last year, DRW8 shows a small growth in Revenue. The Revenue has grown by 2.14% in the last year.
Measured over the past years, DRW8 shows a small growth in Revenue. The Revenue has been growing by 3.92% on average per year.
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%

3.2 Future

The Earnings Per Share is expected to grow by 7.93% on average over the next years.
DRW8 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.15% yearly.
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y3.15%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DRW8.DE Yearly Revenue VS EstimatesDRW8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
DRW8.DE Yearly EPS VS EstimatesDRW8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.79 indicates a reasonable valuation of DRW8.
Compared to the rest of the industry, the Price/Earnings ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 98.39% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.92. DRW8 is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 7.73, the valuation of DRW8 can be described as very cheap.
93.55% of the companies in the same industry are more expensive than DRW8, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.46. DRW8 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.79
Fwd PE 7.73
DRW8.DE Price Earnings VS Forward Price EarningsDRW8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DRW8 is valued cheaper than 96.77% of the companies in the same industry.
DRW8's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DRW8 is cheaper than 96.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.77
EV/EBITDA 3.12
DRW8.DE Per share dataDRW8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

DRW8's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.63
PEG (5Y)0.24
EPS Next 2Y11.08%
EPS Next 3Y11.69%

7

5. Dividend

5.1 Amount

DRW8 has a Yearly Dividend Yield of 3.46%.
Compared to an average industry Dividend Yield of 1.11, DRW8 pays a better dividend. On top of this DRW8 pays more dividend than 91.94% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, DRW8 pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.46%

5.2 History

The dividend of DRW8 is nicely growing with an annual growth rate of 51.02%!
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
DRW8.DE Yearly Dividends per shareDRW8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

31.13% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
The dividend of DRW8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP31.13%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
DRW8.DE Yearly Income VS Free CF VS DividendDRW8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M
DRW8.DE Dividend Payout.DRW8.DE Dividend Payout, showing the Payout Ratio.DRW8.DE Dividend Payout.PayoutRetained Earnings

DRAEGERWERK AG

FRA:DRW8 (12/29/2025, 10:59:49 AM)

56.7

-0.3 (-0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29 2025-10-29
Earnings (Next)03-24 2026-03-24
Inst Owners10.23%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.06B
Revenue(TTM)3.42B
Net Income(TTM)120.88M
Analysts81.33
Price Target82.49 (45.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.46%
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP31.13%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.26%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 8.79
Fwd PE 7.73
P/S 0.31
P/FCF 7.77
P/OCF 5.24
P/B 0.71
P/tB 0.91
EV/EBITDA 3.12
EPS(TTM)6.45
EY11.38%
EPS(NY)7.34
Fwd EY12.94%
FCF(TTM)7.29
FCFY12.87%
OCF(TTM)10.82
OCFY19.08%
SpS182.27
BVpS80.37
TBVpS62.21
PEG (NY)1.63
PEG (5Y)0.24
Graham Number108
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 8.02%
ROCE 10.2%
ROIC 7.67%
ROICexc 8.64%
ROICexgc 10.67%
OM 6.02%
PM (TTM) 3.54%
GM 45.35%
FCFM 4%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score7
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.16
Debt/EBITDA 0.44
Cap/Depr 44.92%
Cap/Sales 1.93%
Interest Coverage 11.48
Cash Conversion 57.51%
Profit Quality 113.22%
Current Ratio 1.76
Quick Ratio 1.03
Altman-Z 2.64
F-Score7
WACC6.49%
ROIC/WACC1.18
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y3.15%
EBIT growth 1Y12.74%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year83.49%
EBIT Next 3Y27.99%
EBIT Next 5Y13.46%
FCF growth 1Y20.52%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y11.8%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%

DRAEGERWERK AG / DRW8.DE FAQ

Can you provide the ChartMill fundamental rating for DRAEGERWERK AG?

ChartMill assigns a fundamental rating of 5 / 10 to DRW8.DE.


What is the valuation status for DRW8 stock?

ChartMill assigns a valuation rating of 7 / 10 to DRAEGERWERK AG (DRW8.DE). This can be considered as Undervalued.


What is the profitability of DRW8 stock?

DRAEGERWERK AG (DRW8.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of DRAEGERWERK AG (DRW8.DE) stock?

The Price/Earnings (PE) ratio for DRAEGERWERK AG (DRW8.DE) is 8.79 and the Price/Book (PB) ratio is 0.71.


Can you provide the expected EPS growth for DRW8 stock?

The Earnings per Share (EPS) of DRAEGERWERK AG (DRW8.DE) is expected to grow by 5.38% in the next year.